- Category
- Micro (2024-25)
- Udyam number
- UDYAM-KR-03-0031181

About Biomoneta Research Private Limited
Data last updated:
Biomoneta Research Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the healthtech and medical tech solutions segment of the healthcare sector. It was incorporated on 07 August 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U73200KA2014PTC075700. Its GSTIN is 29AAGCB0427P1ZD (Karnataka).
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹11.67 Lakh. It is led by directors including Kaveri Das and Srividya Venkatraman Janani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1st Floor 1401 Railway Parallel Road A Block Sahakara Nagar, Bangalore, Karnataka, India – 560092.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.19 Lakh, a growth of 16% compared to the previous year. For the same year it recorded a net loss of ₹2.35 Cr and EBITDA of -₹2.17 Cr. Revenue has declined at a compounded annual rate (CAGR) of 52% over three years and 28% over five years.
The company is associated with 1 brand: Biomoneta. Court records list 3 cases involving the company, including 3 filed by the company. The company has 7 deals on record (3 funding rounds, 2 rights issues, 2 secondary share transfers), with disclosed funding of ₹4.95 Cr; the latest was in June 2020. The company has 5 MSME Form 1 returns on record between 2019 and 2022, listing 6 overdue payments to 6 micro and small suppliers.
Biomoneta Research Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0031181). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website biomoneta.com.
Company details
Recognitions & Rankings of Biomoneta Research
Contact details
Biomoneta Research Private Limited's registered office is in Bangalore, Karnataka. Its website is biomoneta.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address1st Floor 1401 Railway Parallel Road A Block Sahakara Nagar, Bangalore, Karnataka, India – 560092
- IndustryHealthcare, HealthTech & Medical Tech Solutions
To see the full contact details of Biomoneta Research Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Biomoneta Research operates one associated brand: Biomoneta. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pathogenic microbes are extracted and killed by developed devices. | biomoneta.com |
Business activity
The main business activities of Biomoneta Research are professional, scientific and technical and manufacturing. In detail, this covers scientific research and development and electrical equipment, general purpose and special purpose machinery & equipment, transport equipment. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | |
| C | Manufacturing | C10 | Electrical equipment, General Purpose and Special purpose Machinery & equipment, Transport equipment |
To see the full business activity and turnover split of Biomoneta Research Private Limited, buy the company report.
Financials of Biomoneta Research Private Limited
FY 2025 filings availableBiomoneta Research Private Limited reported revenue of ₹5.19 Lakh (up 16% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 16% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 28%. EBITDA fell 58% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.17 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.35 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Biomoneta Research Private Limited, buy the company report.
Board of directors of Biomoneta Research Private Limited
Biomoneta Research has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kaveri Das | Director | 16 Feb 2019 | 7 Years 8 Months | Current |
| Srividya Venkatraman Janani | Director | 07 Aug 2014 | 12 Years 3 Months | Current |
| Santanu Datta | Director | 01 Sep 2015 | 11 Years 2 Months | Current |
Auditor
Biomoneta Research Private Limited is audited by SRK & Associates for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SRK & Associates | FY 2022 | 012946S |
Shareholding
The shareholding of Biomoneta Research Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Biomoneta Research Private Limited, buy the company report.
Deals & funding
Biomoneta Research Private Limited has 7 deals on record (3 funding rounds, 2 rights issues, 2 secondary share transfers), with disclosed funding of ₹4.95 Cr; the latest was in June 2020.
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2020 | Funding round · Seed | ₹4.28 Cr | Investors: Beyond Next Ventures, Mutualtotal Growth Advisors LLP , Malpani Ventures |
| May 2020 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| May 2020 | Funding round | ₹59.6 Lakh | Investors: 2 individuals |
| May 2018 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Feb 2017 | Rights issue | ₹50 Lakh | Investors: Escape Velocity Accelerator, an individual |
To see the full deal history of Biomoneta Research Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Biomoneta Research Private Limited has 3 court cases on record: 3 filed by Biomoneta Research. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 0 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Court case (C.A.(COMM.IPD-PAT)) | Filed by the company against an individual | Disposed |
| High Court of Delhi | Writ petition | Filed by the company against an individual | Disposed |
| High Court of Delhi | Court case (W.C.(C)-IPD) | Filed by the company against an individual | Disposed |
To see the full case history of Biomoneta Research Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Biomoneta Research Private Limited has 5 MSME Form 1 returns on record between 2019 and 2022, listing 6 overdue payments to 6 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 6)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Pink Lemonade Communications Private Limited | |||
| an individual supplier | |||
| Snaptech Analyticals Private Limited | |||
| Asher Encarv Imaging LLP | |||
| an individual supplier |
To see the full MSME payment records of Biomoneta Research Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Biomoneta Research has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAGCB0427P1ZD | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Biomoneta Research Private Limited, buy the company report.
Recent activity
Biomoneta Research Private Limited has 6 board changes on record since 2014: 3 appointments and 3 cessations. The latest: Kaveri Das ceased to be Additional Director on 27 Sep 2019.
News
Frequently asked questions
Biomoneta Research is an active private limited company based in Bangalore, Karnataka, India. The company works in healthtech and medical tech solutions, within the healthcare industry. It was incorporated on 07 August 2014 (12+ years old) and is registered under CIN U73200KA2014PTC075700.
Biomoneta Research has 3 current directors:
- Kaveri Das - Director
- Srividya Venkatraman Janani - Director
- Santanu Datta - Director
The latest financial statements of Biomoneta Research on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Biomoneta Research is 29AAGCB0427P1ZD, registered in Karnataka.
The CIN (Corporate Identification Number) of Biomoneta Research is U73200KA2014PTC075700. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Biomoneta Research has 3 court cases on record: 3 filed by the company.
Biomoneta Research was incorporated on 07 August 2014, making it 12+ years old. It is registered with the Registrar of Companies, Bangalore.
Biomoneta Research has 7 deals on record (3 funding rounds, 2 rights issues, 2 secondary share transfers), with disclosed funding of ₹4.95 Cr; the latest was in June 2020.
Kaveri Das ceased to be Additional Director on 27 Sep 2019. Ramachandran Shankar Ajay ceased to be Director on 03 Sep 2019. Kaveri Das was appointed as Director on 16 Feb 2019. Biomoneta Research has 6 board changes on record in total.
Yes, Biomoneta Research is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-03-0031181).
Biomoneta Research has 5 MSME Form 1 returns on record between 2019 and 2022, listing 6 overdue payments to 6 micro and small suppliers. The latest return was filed on 28 Apr 2022.

